Press Releases Sanofi Börse Stuttgart

Equities

SNW

FR0000120578

Market Closed - Börse Stuttgart Other stock markets 01:25:32 29/06/2024 am IST			5-day change	1st Jan Change
90.16 ^EUR	+0.65%		+2.51%	+0.41%

27/06	CAC40: caution prevails ahead of crucial deadlines	CF
27/06	CAC40: consolidates solo, OAT/Bund spread widens to 81Pb	CF

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	27/06	AQ
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	27/06	GL
Press Release: Availability of the Q2 2024 Aide-mémoire	25/06	GL
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee	21/06	GL
List of Companies That Allegedly Left Nigeria Under Tinubu's Presidency Is Not Accurate	21/06	AQ
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran	21/06	GL
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa	20/06	GL
INNATE PHARMA SHARES UPDATED RESULTS FROM THE SANOFI DEVELOPED BLOOD CANCER PHASE SAR443579/IPH6101 TRIAL	18/06	AQ
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024	13/06	PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	11/06	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	11/06	AQ
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	07/06	AQ
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development	06/06	AQ
SANOFI : L’AMMC vise le prospectus relatif à l’augmentation de capital du groupe « SANOFI » réservée aux salariés du groupe	04/06	PU
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3	04/06	GL
Sanofi - Dupixent recommended for EU approval by the CHMP to treat patients with COPD	03/06	AQ
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan	31/05	GL
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD	31/05	GL
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation	31/05	GL
Largest vaccine production plant in Canada opens in Toronto	30/05	AQ